Purchase of a Qiagen EZ2 Connect MDx
Closed Special Notice Posted
- Solicitation number
- 0000HCR1202489306
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Atlanta, Georgia 30329, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) has issued a Special Notice for the sole-source procurement of a Qiagen EZ2 Connect MDx extraction system. This system is required by the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) to support their Laboratory Assay Readiness (LASR) Validation Laboratory.
The purpose of this Special Notice is to inform interested parties of the CDC's intent to award a firm fixed-price purchase order to Qiagen for the EZ2 Connect MDx system. The system must be a fully automated clinical nucleic acid extraction system capable of processing 1 to 24 samples and intended for professional users to purify nucleic acids from biological samples for in vitro diagnostic purposes. Interested parties may submit their interest and capability to respond to this requirement by emailing the contract specialist at zrb4@cdc.gov by 4:00 PM ET on August 30, 2024. The government will consider all responses received but reserves the right to make a sole-source determination based on the responses.
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Qiagen, for the EZ2 Connect MDx extraction system. The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) requires the contractor and/or system to provide:
- A fully automated clinical nucleic acid extraction system that can scalable extract 1 to 24 samples which is intended for professional users to purify nucleic acids from biological samples for in vitro diagnostic purposes.
- Program requires an additional (in-vitro diagnostic) IVD sample preparation system for DNA isolation to support work being performed in the Laboratory Assay Readiness (LASR) Validation Laboratory.
This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b)(1) and 41 USC 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received prior to the date and time below will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at zrb4@cdc.gov by 4:00PM (ET) on 8/30/2024.
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of Intent to Sole Source a Thermo Orbitrap Fusion Lumos and Thermo RSLCnano UPLC Maintenance Agreement | CDC Office of Acquisition Services | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity